Printed from Voxsanity (voxsanity.com.au) — NCT07122102 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes
Type 2 Diabetes Trial, Not Yet Recruiting
NCT07122102
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are able to understand the trial and are willing to sign a consent form agreeing to take part.
- People who are 18 years of age or older.
- People who have been diagnosed with type 2 diabetes.
- People whose blood sugar has been managed only through diet and exercise, with no diabetes or blood sugar-lowering medications ever taken.
- People whose HbA1c (a measure of average blood sugar over several months) is between 7.0% and 9.0% at the time of joining the trial.
- People whose fasting blood sugar level is no higher than 11 mmol/L at the time of joining the trial.
- People whose body mass index (BMI, a measure of weight relative to height) is between 18 and 35 at the time of joining the trial.
- People who are willing to keep their eating and exercise habits consistent throughout the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had a known allergic reaction to any ingredient in the trial medication or closely related substances.
- People with a history of diabetic ketoacidosis, type 1 diabetes, a pancreas or insulin cell transplant, or diabetes caused by pancreas disease or removal.
- People who have had a serious heart attack, stroke, or mini-stroke (TIA) within the 3 months before signing consent.
- People with severe heart failure (classified as NYHA Class III or IV, meaning significant limitations on physical activity) (confirm with trial site).
- People with very high blood pressure that is not controlled (top number at or above 180, or bottom number at or above 110 mmHg).
- People whose liver enzyme levels (ALT, AST, or ALP) are more than three times the upper limit of normal on blood tests at screening.
- People with severely reduced kidney function (based on a blood test result called eGFR below 25).
- People with long-term gut or digestive conditions that cause significant problems absorbing food.
- People with conditions that could be made worse by excess intestinal gas, such as certain hernia types, intestinal blockage, or ulceration (confirm with trial site).
- People who have had weight-loss surgery or a gut procedure affecting food absorption within the past 2 years.
- People who have taken weight-loss medications in the 3 months before consent, or whose weight has been unstable around the time of screening.
- People who have had cancer (other than a type of minor skin cancer called basal cell carcinoma) within the past 5 years, or who are currently receiving cancer treatment.
- People who have HIV.
- People with severe disease affecting the blood vessels in their limbs.
- People with blood disorders that cause breakdown of red blood cells, such as hemolytic anemia, malaria, or babesiosis.
- People currently taking steroid medications throughout their body (systemic corticosteroids), those who have had a change in thyroid hormone medication dose within the past 6 weeks, or people with uncontrolled hormone or gland disorders other than type 2 diabetes.
- People with substance use issues within the 3 months before the trial, or ongoing conditions that may make it difficult to follow the trial requirements.
- People who are pregnant, breastfeeding, or not willing to use effective contraception during the trial (applies to both females and males where relevant).
- People who have taken part in another clinical trial within 30 days before screening.
- People considered unsuitable for any other reason, as determined by the trial doctor.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
30 June 2027
Where this trial is recruiting
🇨🇳 China
Primary endpoints
HbA1c
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.